Bills/S. 1818

Prescription Drug Price Relief Act of 2025

Prescription Drug Price Relief Act of 2025

In CommitteeHealthcareSenateSenate Bill · 119th Congress
Bill Progress · Senate
Introduced
Committee
Passed House
Passed Senate
Passed Both
Signed

Plain Language Summary

# Prescription Drug Price Relief Act of 2025 - Summary **What the Bill Would Do** The Prescription Drug Price Relief Act of 2025 is designed to lower the cost of prescription medications for Americans. While specific details aren't available in the basic bill information provided, bills with this title typically aim to give the federal government more power to negotiate drug prices directly with pharmaceutical companies, similar to how Medicare can negotiate prices for some drugs.

The legislation would primarily affect patients who purchase prescription drugs, pharmaceutical companies that manufacture them, and Medicare/insurance programs. **Current Status** The bill (S 1818) was introduced in the 119th Congress by Senator Bernie Sanders (I-VT) and is currently in committee, meaning it hasn't yet been voted on by the full Senate. At this stage, it's being reviewed and discussed by the relevant Senate committee before any further action. **Next Steps for More Information** To understand the specific provisions and details of what this bill proposes, you would need to review the full text on Congress.gov or track its progress through the legislative process.

Advertisement

Latest Action

May 20, 2025

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Sponsor

7 cosponsors

Key Dates

Introduced
May 20, 2025
Last Updated
May 20, 2025
Read Full Text on Congress.gov →
Advertisement